| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 237,671 | 241,458 | 331,989 | 478,066 | | Cost of Revenue | 179,901 | 173,853 | 227,227 | 304,003 | | | Gross Profit | 57,770 | 67,605 | 104,762 | 174,063 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 41,071 | 45,395 | 48,706 | 69,249 | | Non Recurring | 160,463 | (1,350) | 689 | 74,496 | | Others | 44,477 | 43,191 | 44,756 | 45,851 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (188,241) | (19,631) | 10,611 | (15,533) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (883) | 681 | 166 | (5,453) | | Earnings Before Interest And Taxes | (189,124) | (18,950) | 10,777 | (20,986) | | Interest Expense | 9,082 | 10,181 | 9,648 | 10,653 | | Income Before Tax | (198,206) | (29,131) | 1,129 | (31,639) | | Income Tax Expense | (73,189) | (10,658) | 225 | 11,261 | | Minority Interest | 75 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (124,942) | (18,473) | 904 | (42,900) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (124,942) | (18,473) | 904 | (42,900) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($124,942) | ($18,473) | $904 | ($42,900) |
|
0.01% Nasdaq 
0.22%
Income Statement
